×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Freeline Therapeutics Holdings plc. (FRLN) NASDAQ

$6.48 - (-)

Market Cap: -

As of 02/16/24 04:00 PM EST. Market closed.

(FRLN)

Freeline Therapeutics Holdings plc. (FRLN)
NASDAQ

$6.48
- (-)

Market Cap: -

As of 02/16/24 04:00 PM EST. Market closed.

Add to Portfolio

freeline is a biopharmaceutical company focused on the development and commercialisation of gene therapies for bleeding and other debilitating disorders based on a next-generation aav gene therapy platform developed by amit nathwani, professor of haematology at ucl and cso of freeline therapeutics ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire, Stevenage, SG1 2FX.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Address
Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire, Stevenage, SG1 2FX.
PRICE CHART FOR FREELINE THERAPEUTICS HOLDINGS PLC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$6.48
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
2,432,290
Open
-
Previous Close
$6.48
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
2,432,290
FINANCIAL STATEMENTS FOR FREELINE THERAPEUTICS HOLDINGS PLC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

FUNDS WITH A POSITION IN FREELINE THERAPEUTICS HOLDINGS PLC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC34,4600.00034%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR FREELINE THERAPEUTICS HOLDINGS PLC
STOCK BUYBACKS FOR FREELINE THERAPEUTICS HOLDINGS PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
1.32%
1Q
09/30/2023
03/31/2023
-0.60%
2Q
09/30/2023
12/31/2022
0.68%
3Q
09/30/2023
09/30/2022
0.60%
4Q
09/30/2023
06/30/2022
21.99%
5Q
09/30/2023
03/31/2022
53.29%
6Q
09/30/2023
12/31/2021
82.82%
7Q
09/30/2023
09/30/2021
82.99%
8Q
09/30/2023
06/30/2021
83.21%
9Q
09/30/2023
03/31/2021
83.34%
10Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
1.32%
1Q
03/31/2023
-0.60%
2Q
12/31/2022
0.68%
3Q
09/30/2022
0.60%
4Q
06/30/2022
21.99%
5Q
03/31/2022
53.29%
6Q
12/31/2021
82.82%
7Q
09/30/2021
82.99%
8Q
06/30/2021
83.21%
9Q
03/31/2021
83.34%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR FREELINE THERAPEUTICS HOLDINGS PLC
LOADING...